Teva to sell 79 drugs to gain approval for Allergan’s generic business

(July 29, 2016) -- Teva Pharmaceutical Industries will sell the rights and assets related to 79 pharmaceutical products to settle the government’s anticompetitive claims surrounding its $40.5 billion purchase of Allergan’s generic drug business....

Related Sections